Femasys (NASDAQ:FEMY) Stock Rating Upgraded by Wall Street Zen

Femasys (NASDAQ:FEMY) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Several other equities analysts have also recently commented on the company. Lake Street Capital assumed coverage on Femasys in a report on Tuesday. They issued a “buy” rating and a $1.50 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Femasys in a research report on Thursday, January 22nd. Finally, Laidlaw started coverage on Femasys in a research note on Thursday, November 20th. They issued a “buy” rating and a $6.50 target price for the company. Four equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $5.50.

Femasys Stock Up 0.4%

Shares of FEMY opened at $0.53 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.61 and a current ratio of 1.16. The company has a 50-day simple moving average of $0.57 and a 200-day simple moving average of $0.62. Femasys has a 52 week low of $0.31 and a 52 week high of $1.76. The firm has a market capitalization of $30.99 million, a P/E ratio of -0.74 and a beta of -2.53.

Institutional Investors Weigh In On Femasys

Large investors have recently made changes to their positions in the company. Kovack Advisors Inc. bought a new position in Femasys during the 4th quarter valued at about $27,000. Jane Street Group LLC acquired a new position in Femasys in the fourth quarter valued at about $62,000. Geode Capital Management LLC grew its stake in Femasys by 50.8% during the fourth quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock worth $224,000 after buying an additional 131,052 shares during the last quarter. Banco BTG Pactual S.A. acquired a new stake in shares of Femasys during the fourth quarter worth approximately $88,000. Finally, State Street Corp increased its holdings in shares of Femasys by 43.5% during the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock worth $47,000 after buying an additional 24,500 shares in the last quarter. Institutional investors own 65.27% of the company’s stock.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.